Search

Search Constraints

You searched for: Author/Creator Drandi, Daniela

Search Results

2. Droplet Digital PCR Assay for MYD88L265P: Clinical Applications in Waldenström Macroglobulinemia. Issue 1 (February 2020)

3. Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. Issue 2 (3rd April 2020)

4. Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. (25th September 2022)

5. Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma. Issue 5 (28th August 2020)

6. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. (23rd January 2014)

7. Minimal residual disease (MRD) in non‐Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network. Issue 4 (16th August 2019)

8. Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐up. (2nd April 2017)

9. Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network. Issue 10 (6th October 2021)

10. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma. Issue 3 (31st March 2021)